Professor | Li Feng | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Li Feng
Contact Information	lifeng@hrbmu.edu.cn
Language ability	Chinese, English
Province	Heilongjiang

Upload Avatar (500 x 500)

Name

Li Feng

Contact Information

lifeng@hrbmu.edu.cn

Language ability

Chinese, English

Province

Heilongjiang

University/Lab Affiliation and Title	Harbin Medical University
Faculty	College of Bioinformatics Science and Technology
Academic Background & Achievements	2006-2014: Master's in Biomedical Engineering, Harbin Medical University 2019: PhD in Biomedical Engineering, Harbin Medical University Published 31 SCI papers with a cumulative impact factor over 100
Work Experience	2014-present: Associate Researcher at Harbin Medical University 2019-present: Joined the Postdoctoral Research Station in Biology at Harbin Medical University
Awards	2019: Second Prize for Outstanding Scientific Research Achievements in Higher Education Institutions by the Ministry of Education of the People's Republic of China

University/Lab Affiliation and Title

Harbin Medical University

Faculty

College of Bioinformatics Science and Technology

Academic Background & Achievements

2006-2014: Master's in Biomedical Engineering, Harbin Medical University
2019: PhD in Biomedical Engineering, Harbin Medical University
Published 31 SCI papers with a cumulative impact factor over 100

Work Experience

2014-present: Associate Researcher at Harbin Medical University
2019-present: Joined the Postdoctoral Research Station in Biology at Harbin Medical University

Awards

2019: Second Prize for Outstanding Scientific Research Achievements in Higher Education Institutions by the Ministry of Education of the People's Republic of China

Areas of Focus	Single-cell sequencing data analysis of malignant tumors Identification and functional study of non-coding RNA regulatory pathways
Publications	A comprehensive overview of oncogenic pathways in human cancer, Li Feng, 2020 Comprehensive analysis of ncRNA involvement in brain microglia immunology, Li Feng, 2022 Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets, Li Feng, 2022 RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data, Li Feng, 2020 Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer, Li Feng, 2020 Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts, Li Feng, 2022 Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma, Li Feng, 2021 Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data, Li Feng, 2022 Functional regulations between genetic alteration‑driven genes and drug target genes acting as prognostic biomarkers in breast cancer, Li Feng, 2022 Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data, Li Feng, 2019

Areas of Focus

Single-cell sequencing data analysis of malignant tumors
Identification and functional study of non-coding RNA regulatory pathways

Publications

A comprehensive overview of oncogenic pathways in human cancer, Li Feng, 2020
Comprehensive analysis of ncRNA involvement in brain microglia immunology, Li Feng, 2022
Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets, Li Feng, 2022
RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data, Li Feng, 2020
Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer, Li Feng, 2020
Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts, Li Feng, 2022
Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma, Li Feng, 2021
Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data, Li Feng, 2022
Functional regulations between genetic alteration‑driven genes and drug target genes acting as prognostic biomarkers in breast cancer, Li Feng, 2022
Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data, Li Feng, 2019

Single-Cell Sequencing Malignant Tumors Data Analysis Non-Coding Rna Regulatory Pathways Bioinformatics Cancer Research Rna Function Genomics Transcriptomics

Li Xia - Harbin Medical University

Xiao Yun - Harbin Medical University

Juan Xu - Harbin Medical University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us